Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A new treatment for T-cell acute lymphoblastic leukaemia?

10.09.2004


IL-7, a hormone-like protein involved in cell-cell interaction, has been associated with increased survival and expansion of T-cell acute lymphoblastic leukaemia (T-ALL). Now, in the latest issue of the Journal of Experimental Medicine, a team of scientists, not only confirms the essential role of this protein in the disease but also, for the first time, identifies the biochemical pathway affected by IL-7 in T-ALL cells, a discovery which could lead to the development of potential new treatments for the disease.



Leukaemia is a type of blood cancer which originates from an uncontrolled growth of abnormal cells in the bone marrow (usually the white blood cells/lymphocytes). This results in very little space left for the growth of normal cells which leads to a weakened immune system. In the case of acute leukaemia the filling of the bone marrow space is extremely fast and the disease needs immediate treatment or the patient will die.

Leukaemia affects 4 out of every 100,000 people worldwide and is the most common childhood cancer. In the United States alone, every year, more than 2,000 children and almost 27,000 adults are diagnosed with the disease.


Cytokines, such as IL-7, are powerful chemical substances secreted usually, but not only, by the immune system to transmit information/instructions between cells. IL-7 is a potent growth factor for immune cells and is indispensable for normal T-cell development. Several studies have also suggested that IL-7 was involved in T-cell acute lymphoblastic leukaemia’s growth although there was no information on the mechanism(s) behind this effect.

João Barata, Angelo Cardoso, Vassiliki Boussiotis and colleagues at the Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston and at the Tumour Biology Unit, Institute of Molecular Medicine, University of Lisbon, Portugal studied T-ALL cells cultured in the presence of IL-7 trying to understand, not only the real importance of this cytokine in the disease, but also the biochemical mechanism through which IL-7 mediated its effect on T-ALL.

In this paper, the team of researchers describe how they identify, for the first time, the cellular pathway in T-ALL cells which is affected by IL-7 (the pathway identified is called PI3K/Akt(PKB)), an information that can now help scientists in the search for new treatments for the disease.

Barata, Cardoso, Boussiotis and colleagues also discovered that IL-7 affects T-ALL metabolism, increasing energy production in T-ALL cells which results in increased cell division and, ultimately, tumour growth. The team of scientists found as well, that IL-7 presence induces an increase in T-ALL cell size. Interestingly, both phenomena have been previously associated with the induction of cancer.

These results confirmed the role of IL-7 in T-ALL growth and activation and led the team of scientists to suggest that this cytokine is indispensable for T-ALL biology which further highlights the unique importance of IL-7 as a potentially therapeutic target.

Barata, Cardoso, Boussiotis and colleagues write: ”Our results implicate PI3K as a major effector of IL-7-induced viability, metabolic activation, growth and proliferation of T-ALL cells, and suggest that PI3K and its downstream effectors may represent molecular targets for therapeutic intervention in T-ALL.”

Understanding the mechanism behind disease is the first step towards a better treatment with higher efficacy and fewer secondary effects. Leukaemia, like all cancers, is still mostly treated by chemo- and radio-therapy treatments which destroy both cancerous and healthy cells and any alternative therapy that can replace or at least supplement these extremely invasive and not always effective treatments is always good news for patients and doctors alike.

Catarina Amorim | alfa
Further information:
http://www.oct.mct.pt

More articles from Health and Medicine:

nachricht The genes are not to blame
20.07.2018 | Technische Universität München

nachricht Targeting headaches and tumors with nano-submarines
20.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>